ArticleScientific reports2026
Sustainable multifaceted HPLC approach for concurrent quantitation of an octa-mixture used in upper respiratory therapy with a five-dimensional sustainability assessment.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Upper respiratory tract disorders are seriously prevalent disorders that impact people daily all over the world. Antipyretics, analgesics, bronchodilators, antitussives, expectorants, mucolytics, antihistamines, and antibiotics are among the pharmacological classes that are often administered either alone or in combination to treat and manage the symptoms attributed to upper respiratory tract disorders. In the rising era of green analytical chemistry, the development of broad, multi-analyte analytical techniques that can separate and quantify numerous pharmacologically related substances simultaneously is becoming of increasing significance. This work introduces a new, concise, accurate, and robust high performance liquid chromatography method with diode array detection approach for the simultaneous assay of eight substances, namely; Albuterol, Erdosteine, Paracetamol, Amoxicillin, Chlorpheniramine, Guaifenesin and two of the most frequently encountered preservatives that are incorporated in upper respiratory tract medications; Methyl and Propyl Parabens in their bulk and pharmaceutical formulations. An Inertsil octadecyl silane-3 (4.6 × 250 mm, 5 μm) column and a gradient mobile phase system consisting of methanol and 0.025 M potassium dihydrogen orthophosphate buffer (pH 4) were employed to achieve the separation. Chromatograms were detected at 225 nm for Albuterol and Chlorpheniramine, 230 nm for Guaifenesin and Amoxicillin, 236 nm for Erdosteine, 250 nm for Paracetamol, and 256 nm for Methyl and Propyl Parabens using the diode array detector. The suggested approach was successfully verified in compliance with the International Council for Harmonization guidelines with low values of percentage relative error and percentage relative standard deviation (< 2%) and strong correlation coefficients (> 0.9991), demonstrating its good accuracy, precision and linearity. Additionally, an in-depth five-sided examination was conducted to demonstrate the suggested method’s greenness, blueness, violet innovation and sustainability profiles using the analytical GREEnness metric, analytical eco-scale, blue applicability grade index, click analytical chemistry index, violet innovation grade index and white analytical chemistry assessment metrics. This work represents the establishment of a broad spectrum, multianalyte, versatile methodology that would provide an indispensable asset for quality control laboratories in terms of its affordability, speed, sensitivity, and sustainability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.